Literature DB >> 22086919

Reduced immunoglobulin A transcytosis associated with immunoglobulin A nephropathy and nasopharyngeal carcinoma.

Tao Su1, Steven J Chapin, David M Bryant, Annette M Shewan, Kitty Young, Keith E Mostov.   

Abstract

Polymeric IgA (pIgA) is transcytosed by the pIgA receptor (pIgR) across mucosal epithelial cells. After transcytosis to the apical surface, the extracellular, ligand-binding portion of the pIgR is proteolytically cleaved. A missense mutation in human pIgR, A580V, is associated with IgA nephropathy and nasopharyngeal carcinoma. We report that this mutation reduces the rate of transcytosis of pIgR and pIgA, and seemingly the rate of pIgR cleavage. We propose that the defects in pIgR trafficking caused by the A580V mutation may underlie the pathogenesis of both diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086919      PMCID: PMC3247984          DOI: 10.1074/jbc.M111.296731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Immunoglobulin transport across polarized epithelial cells.

Authors:  Raul Rojas; Gerard Apodaca
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

2.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

Review 3.  IgA nephropathy: pathogenesis of the most common form of glomerulonephritis.

Authors:  S N Emancipator; M E Lamm
Journal:  Lab Invest       Date:  1989-02       Impact factor: 5.662

4.  Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus.

Authors:  Y J Gan; J Chodosh; A Morgan; J W Sixbey
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA.

Authors:  W Song; M Bomsel; J Casanova; J P Vaerman; K Mostov
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  [The primary structure of human free secretory component and the arrangement of disulfide bonds].

Authors:  H Eiffert; E Quentin; J Decker; S Hillemeir; M Hufschmidt; D Klingmüller; M H Weber; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1984-12

7.  Human free secretory component is composed of the first 585 amino acid residues of the polymeric immunoglobulin receptor.

Authors:  G J Hughes; S Frutiger; L A Savoy; A J Reason; H R Morris; J C Jaton
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

8.  Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients.

Authors:  Wataru Obara; Aritoshi Iida; Yasushi Suzuki; Toshihiro Tanaka; Fumihiro Akiyama; Shiro Maeda; Yozo Ohnishi; Ryo Yamada; Tatsuhiko Tsunoda; Takashi Takei; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Takashi Ujiie; Yutaka Nagane; Kosaku Nitta; Satoru Miyano; Ichiei Narita; Fumitake Gejyo; Hiroshi Nihei; Tomoaki Fujioka; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-05-10       Impact factor: 3.172

Review 9.  Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity.

Authors:  F-E Johansen; C S Kaetzel
Journal:  Mucosal Immunol       Date:  2011-09-28       Impact factor: 7.313

10.  Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer.

Authors:  Rungnapa Hirunsatit; Narisorn Kongruttanachok; Kanjana Shotelersuk; Pakpoom Supiyaphun; Narin Voravud; Anavaj Sakuntabhai; Apiwat Mutirangura
Journal:  BMC Genet       Date:  2003-01-21       Impact factor: 2.797

View more
  1 in total

1.  Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.

Authors:  Xuanchang Qi; Xuechang Li; Xiuxia Sun
Journal:  Tumour Biol       Date:  2016-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.